FOR IMMEDIATE RELEASE
CHICAGO, UNITED STATES – June 12, 2026 — The Endocrine Society Meeting – ENDO 2026, the premier global gathering for endocrinology, is set to open its doors tomorrow, June 13, in Chicago, IL. This highly anticipated annual event will unite over 7,000 leading experts, researchers, and clinicians from around the world, building on the significant attendance of ENDO 2025. Over four days, ENDO 2026 is poised to showcase groundbreaking advancements in endocrine research, patient care, and a wealth of B2B opportunities across pharmaceutical innovations, biotechnology breakthroughs, and advanced diagnostic solutions.
Organized by the Endocrine Society, the largest global organization dedicated to hormone research and the physicians who treat hormone-related conditions, ENDO 2026 underscores its pivotal role in advancing scientific discovery and improving patient health worldwide. With a community exceeding 18,000 members across 133 countries, the Society leverages this annual meeting to foster unparalleled scientific exchange and strategic B2B engagements within the hormone health and science sector.
Unveiling the Future of Hormone Health and Science
ENDO 2026 will feature an expansive program designed to push the boundaries of endocrine knowledge and clinical application. The event’s core exhibit sectors, Endocrinology Research & Clinical Care and Disease Management & Therapeutic Innovations, will provide deep dives into the latest developments.
- Endocrinology Research & Clinical Care: This sector will highlight foundational scientific inquiry and its direct application in patient treatment. Attendees will explore groundbreaking science, innovative research, and practical insights into hormone health, including over 2,500 abstract presentations. Core technologies on display will encompass genomics, single-cell genomics, molecular mechanisms of hormone signaling, and therapeutic innovation aimed at disease modification.
- Disease Management & Therapeutic Innovations: Focusing on specific endocrine conditions, this sector will showcase cutting-edge solutions for diagnosis and treatment. Key areas include Diabetes & Metabolic Disorders, Obesity & Weight Management, Thyroid, Parathyroid & Adrenal Disorders, Reproductive Endocrinology, Bone & Mineral Metabolism, Pediatric Endocrinology, Neuroendocrinology & Pituitary Disease, and Endocrine Oncology. Exhibitors will present pharmaceutical solutions, advanced diagnostic tools, medical devices, hormone therapy, and precision medicine approaches.
The ENDOExpo, the event's exhibition component, is expected to host over 100 exhibitors, providing a dynamic platform for showcasing the latest products, services, and technologies. Major B2B global brands, including past participants like AbbVie, American Diabetes Association, Amylyx, BridgeBio, Recordati Rare Disease, and Rhythm Pharmaceuticals, alongside healthcare systems like Sutter Health, have historically leveraged this platform for significant industry engagement.
A Global Nexus for Collaboration and Discovery
ENDO 2026 is gearing up to host a diverse target audience, including endocrinologists, physicians, researchers, clinicians, scientists, healthcare executives, pharmaceutical and biotechnology innovators, academic institutions, and medical technology providers. The event will offer over 200 educational sessions, including plenary sessions with world-renowned speakers discussing genomics, sex differences, metabolism, hormone signaling, and therapeutic innovation.
Beyond the scientific presentations, ENDO 2026 will provide extensive opportunities for professional development and networking. Attendees can participate in "Meet the Professor" sessions, Master Clinician sessions, and engaging debates. The ENDOExpo will feature Science & Innovation Theaters and Industry Connect sessions, while networking events such as an International Welcome Reception and a 5K Fun Run/Walk will foster invaluable connections. A dedicated Career Fair will also be available for those seeking new professional opportunities.
For both international exhibitors and professional buyers, ENDO 2026 offers unparalleled visibility and direct access to a highly targeted global audience. It is an invaluable platform to showcase product benefits, engage in meaningful dialogue about industry challenges, and connect with key decision-makers shaping the future of endocrine care. Attendees will benefit from an immersive experience designed to deepen their expertise through groundbreaking science, innovative research, and practical insights, ultimately enhancing clinical practice and fostering professional growth.
For more information, to view the full program, or to register, please visit https://endo2026.endocrine.org/.
###
About Endocrine Society Meeting - ENDO
The Endocrine Society Meeting – ENDO is the premier global gathering in endocrinology and the annual meeting of the Endocrine Society. With a rich history spanning decades, ENDO consistently brings together leading experts, researchers, and clinicians to share the latest developments in endocrine research and patient care. It stands as the largest endocrine-specific meeting globally, fostering scientific exchange and B2B opportunities within the hormone health and science sector.
Media Contact
Contact Name: Media Relations
Company: Endocrine Society Meeting - ENDO Press Office
Email: [email protected]